Merck KGaA wins OK to buy Sigma-Aldrich; warehouse burglary may be replayed in court;

> Merck KGaA has received all of the antitrust approvals needed to move forward with its $17 billion buyout of pharma supply company Sigma-Aldrich. Release

> A trial may come soon for some of those accused of pulling off the largest pharmaceutical warehouse burglary. Story

> WuXi PharmaTech ($WX) has completed a test of the TruTag Technologies' edible tracking system for meds. Release

> Ethiopia is providing incentives in an effort to create a domestic drug production industry to cut the government cost of paying for medications. Story

> India's pharma industry is pressing for more public spending on healthcare, saying the country's infrastructure is among the poorest in the world and spending has been stagnant. Story

> North America has about 35% of the global contract manufacturing market and will continue to lead as it reaches $84 billion by 2020, a report says. Story

Suggested Articles

Drugmakers have voluntarily recalled their generic Zantac from the U.S. market after the FDA raised concerns, but it has not been without a cost.

Just weeks after selling the sterile manufacturing assets of its Kyowa operation in Japan, it has unloaded the rest of its Kyowa drugmaking operation.

India’s Aurobindo, which has yet to close its $1 billion deal to buy 300 Sandoz products in the U.S., continues to rack up FDA issues.